{
    "nctId": "NCT02596867",
    "briefTitle": "Neoadjuvant Propanolol in Breast Cancer",
    "officialTitle": "Pilot \"Window of Opportunity\" Neoadjuvant Study of Propranolol in Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 2,
    "primaryOutcomeMeasure": "Evaluate the Effect of the Beta Blocker Propranolol on Reducing the Tumor Proliferative Index Using Ki-67.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Ages 18- 65\n* diagnosis of stage I-III breast cancer , confirmed by a core biopsy\n* Planning to undergo definitive surgery including mastectomy or breast conserving surgery\n* Systolic blood pressure must be \\>100 mmHg but no more than 140 mmHg and/or diastolic \\> 60 mmHg and no more than 95 mmHg.\n* normal baseline EKG\n\nExclusion criteria:\n\n* Pregnancy; potential subjects of female bearing age will have to complete a pregnancy test during screening to ensure that they are not pregnant. Potential patients who are post-menopausal must have confirmed one year without menstrual cycle.\n* Free of major medical illnesses including:\n* Uncontrolled Diabetes (HbA1c of \u2264 8 if previously tested)\n* Uncontrolled hypertension: BP \\>systolic 140/ diastolic \\> 95\n* Cardiac diseases (history of cardiac valve disease, coronary artery disease, congestive heart failure, A-V block, peripheral vascular disease, any cardiac arrhythmia/bradycardia) with the exception of the diagnosed cancer.\n* Histories of asthma, bronchospastic disease, or obstructive pulmonary disease\n* Previously diagnosed thyrotoxicosis\n* Severe allergic reactions to medications which are included in the beta blocker family\n* Previously or currently treated with a beta adrenergic receptor antagonist\n* Patients with locally advanced or inflammatory breast cancer not amenable to surgical resection\n* Patients taking any of the following medications will be excluded:\n\n  * Drugs that are categorized as digitalis glycosides, beta-blockers and calcium channel blockers, ACE inhibitors and alpha blockers\n  * Amiodarone\n  * Cimetidine\n  * Ciprofloxacin\n  * Delavudin\n  * Dobutamine\n  * Ethanol\n  * Fluconazole\n  * Fluoxetine\n  * Fluvoxamine\n  * Haloperidol\n  * Imipramine\n  * Isoniazid\n  * Isoproterenol\n  * Luvoxamine\n  * Paroxetine\n  * Phenytoin\n  * Phenobarbital.\n  * Propafenone.\n  * Quinidine\n  * Reserpine\n  * Rifampin\n  * Ritonavir\n  * Rizatriptan.\n  * Tenioposide\n  * Theophylline\n  * Thyroxine\n  * Tolbutamide.\n  * Warfarin\n  * Zileuton\n  * Zolmitriptan",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}